Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 2, 2005, Pages 243-246

  Knab, J ^a   Goos, M ^a   Dissemond, Joachim ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b University School of Medicine   (Germany)

Author keywords

Leflunomide; Leg ulcer; Rheumatoid arthritis; Vasculitis

Indexed keywords

COLESTYRAMINE; GOLD; IMMUNOMODULATING AGENT; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; LEG ULCER; PAIN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BLEEDING; SKIN FIBROSIS; SKIN INFLAMMATION; SPLIT THICKNESS SKIN GRAFT; TREATMENT FAILURE; TREATMENT OUTCOME; ULCER HEALING; VASCULITIS; WOUND CARE; WOUND HEALING IMPAIRMENT;

AGED; ARTHRITIS, RHEUMATOID; CHOLESTYRAMINE; DEBRIDEMENT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LEG ULCER; SKIN TRANSPLANTATION; VASCULITIS; WOUND HEALING;

EID: 16244384690     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01118.x     Document Type: Article

References (19)

1. Fox RI. Mechanism of action of Leflunomide in rheumatoid arthritis. J Rheumatol 1998; 25: 20-26.
2. Holm EA, Balsev E, Jemec GBE. Vasculitis occurring during leflunomide therapy. Dermatology 2001; 203: 258-259.
3. McCoy CM. Leflunomide-associated skin ulceration. Ann Pharmacother 2002; 336: 1009-1011.
4. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-662.
5. Canonne-Courivaud D, Carpentier O, Dejobert Y, Hachulla E, Delaporte E. Lichenoid drug reaction to leflunomide. Ann Dermatol Venereol 2003; 130: 435-437.
6. Sibbitt WL, Williams RC. Cutaneous manifestations of rheumatoid arthritis. Int J Dermatol 1982; 21: 563-572.
7. Jorizzo JL, Daniels JC. Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol 1983; 8 439-457.
8. Cawley MI. Vasculitis and ulceration in rheumatic diseases of the foot. Baillieres Clin Rheumatol 1987; 1: 315-333.
9. Pun YLW, Barraclough DRE, Muirden KD. Leg ulcers in rheumatoid arthritis. Med J Aust 1990; 158: 585-587.
10. Walchner M, Messer G, Meurer M et al. Hautulzerationen bei rheumatoider Arthritis. Hautarzt 1995; 46: 406-412.
11. Veraguth AJ, Häuselmann HJ, Hunziker T, Gerber NJ. Vaskulitische Hautläsionen bedingt durch nicht-steroidale Antiphlogistika. Schweiz Med Wochenschr 1992; 122: 923-929.
12. McRorie ER, Jobanputra P, Ruckley CV, Nuki G. Leg ulceration in rheumatoid arthritis. Br J Rheumatol 1994; 33: 1978-1984.
13. Thurtle OA, Cawley MI. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol 1983; 10: 507-572.
14. Scott DGI, Bacon PA. Intravenous cyclophosphamide and methylprednisolone in the treatment of systemic rheumatoid vasculitis. Am J Med 1984; 76: 337-384.
15. Watts RA, Scott DGI. Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 1997; 11: 191-217.
16. Meister HP. Vaskulitis mit begleitenden Hautveränderungen bzw. Dermatosen mit begleitender Vaskulitis. Pathologe 2002; 23 111-117.
17. Mackel SE, Jordon RE. Leucocytoclastic vasculitis. Arch Dermatol 1982; 118: 296-301.
18. Manna SK, Aggarwal BB. Immunosuppressive Leflunomide metabolite (A 77 1999, 1726 blocks TNF-dependent nuclear factor kappaB activation and gene expression. J Immunol 162: 2095-2102.
19. Strand V, Cohen S, Schiff M et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 1999; 159: 2542-2550.